T. Rowe Price Investment Management, Inc. Ionis Pharmaceuticals Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 12,639,684 shares of IONS stock, worth $478 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
12,639,684
Previous 13,317,112
5.09%
Holding current value
$478 Million
Previous $577 Million
4.35%
% of portfolio
0.38%
Previous 0.35%
Shares
8 transactions
Others Institutions Holding IONS
# of Institutions
395Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$524 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$390 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$312 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$248 Million0.06% of portfolio
-
State Street Corp Boston, MA4.19MShares$158 Million0.01% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.37B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...